Big variations in price from provider to provider could be adding to your bills—even if you're insured.» Read More
Like many of the 2,200-plus people who showed up for a 5:30 a.m. dental clinic last month, Patty Kennedy knows that bad teeth translate into poor employment prospects.
Cyclicals are heating up as the summer approaches and the economy starts to show signs of improvement, analysts say.
GlaxoSmithKline fired the head of its R&D operations in China after a tipster spurred an inquiry that found "misrepresented" data were used in a multiple sclerosis study.
Obama administration to scrap age restrictions on the sale of morning-after pills, making the emergency contraception available to women and girls of any age without a prescription.
Obamacare's implementation may look like a "train wreck," but Universal Health Services CEO Alan Miller says his $7 billion hospital company is well-positioned for the changes.
Months after the Komen Foundation's decision to cut Planned Parenthood funding sparked widespread backlash, the group's CEO still holds her position and received a large raise.
Transplant experts will meet to decide whether and how to change the rules for children, after the parents of two youngsters successfully sued to get restrictions temporarily lifted.
AstraZeneca is to buy U.S. respiratory drug specialist Pearl Therapeutics for up to $1.15 billion, as Britain's second biggest drugmaker steps up a drive to rebuild its product pipeline via deal-making.
Allergy season has been getting longer every year for 15 years, with Dr. Michael Foggs of American College of Allergy, Asthma and Immunology; and Stephen Brozak, WBB Securities, discusses the big money in the allergy business.
With its cheap multiple and serious upside potential, Cramer thinks this stock could give your portfolio a kick.
CNBC's John Harwood provides perspective on President Obama's address on health care, invasion of privacy concerns, and his meeting later today with China's President Xi.
President Obama answers questions about privacy concerns surrounding the NSA's collection of telephone records and monitoring of Internet activity. "Congress is continually briefed" on how these activities are conducted, Obama says.
President Obama explains the "two main things Americans need to know" about the new legislation on health care. The President outlines how competition will provide an incentive to keep health care costs down, and cover millions of people who currently don't have insurance coverage.
CNBC's John Harwood provides a preview of the President's address on the benefits of the Affordable Care Act. He also addresses the NSA phone records issue.
CNBC's John Harwood presents a preview of President Obama's statement on the Affordable Care Act, and likely comments on this morning's better-than-expected jobs number, as pressure mounts for him to address NSA privacy concerns ahead of his meeting later today with China's President Xi.
Royalty Pharma raised its hostile bid for Irish drug firm Elan to a potential $8 billion on Friday, coming back for the third time after just 7.5 percent of shareholders accepted the last offer.
A new study released Friday discovered that an average of 15 percent of flexible endoscopes used to examine GI tracts and colons at five hospitals were dirty.
Joseph Jimenez, CEO of Novartis, says the pharmaceutical company is investing heavily to introduce new drugs in China as the spotlight shifts from infectious to chronic disease.
Mark Bertolini, Chairman, Chief Executive Officer and President of Aetna, weighs in on the President's comments last night about the state of the nation's health care system, and how to bring down health care costs.
CNBC's Eamon Javers reports the CBO projects 2020 Medicare/Medicaid spending to be $200 billion, which is 15 percent less than projected.
Get the best of CNBC in your inbox